Results 51 to 60 of about 41,154 (301)
Psychiatry and Clinical Psychopharmacology, 2021 The history of psychiatric disorders affecting mental status of the patients, and drugs used in their treatments went back to the beginning of human history. To evaluate the current status of psychiatry and psychopharmacology in Turkey and in the world,
Özcan Köknel
doaj
Neuroinflammation in Schizophrenia: A Critical Review and The Future
Psychiatry and Clinical Psychopharmacology, 2021 Schizophrenia is a serious mental illness that affects approximately 1% of the population worldwide, with positive, negative and cognitive dysfunctions and a significant deterioration in psychosocial functioning.
Feyza Aricioglu +5 more
doaj +1 more source
Journal of Applied Toxicology, EarlyView.ABSTRACT Environmental contaminants like bisphenol A (BPA) and nonylphenol (NP) are recognized neurotoxicants; however, the molecular mechanisms underlying their impact on sensory ganglia, specifically the trigeminal ganglion (TG), remain critically underexplored.
Betül Yazğan +3 more
wiley +1 more source
Planning impairment in schizophrenia: The possible role of abstract thinking and short-term memory
European Psychiatry, 2021 Introduction The planning impairment is one of the basic aspect of cognitive dysfunction, but its mechanisms in schizophrenia remain unclear. Objectives To assess the links between planning and cognitive functioning in schizophrenic patients and in ...
A. Alekseev, M. Morozova, G. Rupchev
doaj +1 more source
Psychiatric safety of ketamine in psychopharmacology research
, 2007 RATIONALE: A growing number of investigators are studying ketamine effects in healthy human subjects, but concerns remain about its safety as a research tool.
조현상
core +1 more source
Steroidopathies and hormonal imbalance in children and adolescents with autism spectrum disorder
JCPP Advances, EarlyView.Abstract Background Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with a multifactorial etiology, many aspects of which remain unclear. Emerging evidence suggests a potential association between ASD and clinical manifestations resulting from hormonal imbalances, henceforth named “steroidopathies.” The present study aims to ...
Concetta de Giambattista +5 more
wiley +1 more source
JCPP Advances, EarlyView.Abstract Background Attention‐deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition with significant cognitive and social impacts. Identifying reliable biomarkers for ADHD is crucial for developing personalised therapies. Electroencephalography (EEG) alpha oscillations (8–12 Hz) have been suggested as a potential biomarker, but ...
Julio Rodriguez‐Larios +2 more
wiley +1 more source
Psychopharmacology of Addiction [PDF]
Psikiyatride Güncel Yaklaşımlar, 2012 Addiction is a primary, chronic, neurobiological disease, with genetic, psychosocial, and environmental factors influencing its development. Developments in the psychopharmacology of addiction is much slower than the other disciplines of psychiatry.
Tugce Toker Ugurlu +2 more
doaj
PSYCHOPHARMACOLOGY OF HYPNOTICS
Psychiatry and Clinical Psychopharmacology, 2021 The following article identifies the appropriate strategies for the prescription of hypnotic drugs. Initially, a clinical evaluation of insomnia is provided which includes definitions of good and poor sleepers and the physiology of sleep. The paper then
Michel Bourin +1 more
doaj
, 2009 Previous studies have shown that cannabinoid CB1 receptors play an important role in specific aspects of learning and memory, yet there has been no systematic study focusing on the involvement of cannabinoid CB1 receptors in methamphetamine-related ...
Mei Zhao +17 more
core +1 more source